CAS: 125455-64-3; N-((2R,3R,4R,5R,6R)-4-(((2R,3R,4R,5S,6R)-3-Acetamido-4,5-Dihydroxy-6-(Hydroxymethyl)Tetrahydro-2H-Pyran-2-yl)Oxy)-5-Hydroxy-6-(Hydroxymethyl)-2-(4-Nitrophenoxy)Tetrahydro-2H-Pyran-3-yl)Acetamide

该化合物是属于胶质表面的化学化合物,特别是N-乙基基甲基甲胺的衍生物.它有一个p-硝基苯组,以其在各种生物化学应用中使用而著称,特别是在酶试验中作为铬诱导亚速率.乙胺组的存在表明,该化合物具有可影响其溶解性和再活动作用的氨化功能.该化合物的典型特征是其分子结构,其中包括一个苯球环和多个可参与氢联结和其他相互作用的功能组.它经常用于研究环境,特别是在涉及碳水化合物化学和酶反应的研究中.该化合物的特性,例如溶性,稳定性和再活性,可能因具体条件和其他试剂的存在而不同.在处理和储存准则方面,应参考安全数据表,如与任何化学物质一样,用于处理和储存.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号1147438-51-4 3,4,6-Tri-O-ace... | CAS号100-02-7 对硝基苯酚 | CAS号1316823-24-1 p-nitrophenyl 3... | CAS号210418-04-5 4-硝基苯基 2-脱氧-2-叠... | CAS号1316822-99-7 p-nitrophenyl 2... | CAS号83025-20-1 2-azido-3,4,6-t...

合成工艺路线路线简述

    📜3,4,6-Tri-O-Acetyl-2-Azido-2-Deoxy-α-D-Galactopyranosyltrichloroacetimidate置于4-二甲氨基吡啶,N-碘代丁二酰亚胺,三氟甲磺酸三甲基硅酯,水,Sodium Methylate,对甲苯磺酸,溶剂黄146,肼体系中,用 吡啶,甲醇,乙醇,二氯甲烷,N,N-二甲基甲酰胺,乙腈 用作溶剂,化学反应 54.66H,反应生成2-乙酰氧基-3-O-(2-乙酰氧基-2-脱氧-B-D-吡喃糖苷)-2-脱氧-A-D-半乳糖苷-4-硝基苯酯
    参考文献:粘蛋白o-聚糖核心结构的对硝基和对氨基苯基糖苷的合成
    标题:粘蛋白o-聚糖核心结构的对硝基和对氨基苯基糖苷的合成
    摘要:为了研究糖苷酶和构建聚糖阵列,已经使用d-半乳糖化学合成了粘蛋白o-聚糖核心结构1-7和2,6-St-抗原的对硝基苯基和对氨基苯基糖苷.作为galnac残基的前体.使用4,6-二-O-苯甲酰基-2,3-N,O-恶唑烷酮保护的供体部分引入了glcnac残基,其允许在一个步骤中使用甲醇钠对所形成的二糖和三糖进行脱保护.
    Doi:10.1016/j.Carres.2011.03.036

    海关参考信息

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Specificity Of β1,4-Galactosyltransferase Inhibition By 2-Naphthyl 2-Butanamido-2-Deoxy-1-Thio-β-D-Glucopyranoside
    作者:Yin Gao,Carmen Lazar,Walter A. Szarek,Inka Brockhausen |发布日期:2010.10
    摘要:Inhibitors Of Galactosyltransferase (Galt) Have The Potential Of Reducing The Amounts Of Adhesive Carbohydrates On Secreted And Cell Surface-Bound Glycoproteins. We Recently Found A Potent Inhibitor Of β4Galt, 2-Naphthyl 2-Butanamido-2-Deoxy-1-Thio-β-D-Glucopyranoside (Compound 612). In This Work, We Have Tested Compound 612 For The Specificity Of Its Inhibition And Examined Its Effect On Galt, And On Glcnac- And Galnac-Transferases In Homogenates Of Different Cell Lines, As Well As On Recombinant Glycosyltransferases. Compound 612 Was Found To Be A Specific Inhibitor Of β4Galt. The Specificity Of Recombinant Human β3Galt5 That Also Acts On Glcnac-R Substrates, Revealed Similarities To Bovine Milk β4Galt. However, 612 Was A Poor Substrate And Not An Inhibitor For β3Galt5. To Further Determine The Specific Structures Responsible For The Inhibitory Property Of 612, We Synthesized (2-Naphthyl)-2-Butanamido-2-Deoxy-β-D-Glucopyranosylamine (Compound 629) Containing Nitrogen In The Glycosidic Linkage, And Compared It To Other Naphthyl And Quinolinyl Derivatives Of Glcnac As Substrates And Inhibitors. Compound 629 Was A Substrate For Both β4Galt And β3Galt5. This Suggests That Properties Of 612 Other Than The Presence Of The Naphthyl Ring Alone Were Responsible For Its Inhibitory Action. The Results Suggest A Usefulness Of 612 In Specifically Blocking The Synthesis Of Type 2 Chains And Thus Epitopes Attached To Type 2 Chains. In Addition, 612 Potently Inhibits β4Galt In Cell Homogenates And Thus Allows Assaying β3Galt Activity In The Presence Of β4Galt.

    合成参考文献

    参考DOI号:10.1016/j.carres.2011.03.036
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知